Is BSX stock a Buy, Sell, or Hold?

Based on our analysis, BSX is currently a HOLD with moderate confidence. 📊 HOLD: BSX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BSX stock?

Our analysis estimates the fair value range for BSX to be between $55.58 and $63.40. The current price is $53.55.

What is the analyst price target for BSX?

The average Wall Street analyst price target for BSX is $85.19. This implies a potential upside of 60.5% from current levels.

BSX Stock Analysis: Buy, Sell, or Hold?

BSX - Boston Scientific Corp.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

$53.55

0.49 (0.92%) ▲

5d: -5.34%

30d: -17.12%

90d: -27.75%

HOLD

MODERATE Confidence

Protect Your BSX Gains

Analysis Updated: May 14, 2026 12:00 AM ET

Earnings: Apr 22, 2026 0d

Smart Money Accumulation

BSX is down 5.3% this week, but smart money is accumulating calls. Top strike: $65 2026-06-18 with 9,330 OI. Call ratio: 66% View Scanner →

Strength: 4.3/10

Get Alerted When BSX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BSX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 11.4%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$115.46

Based on 7.7% avg growth

INTRINSIC VALUE TODAY

$71.69

25.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.2x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BSX is currently trading at $53.55, which is considered oversold relative to its 30-day fair value range of $55.58 to $63.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.1) compared to its historical average (21.2). Remarkably, the market is currently pricing in an annual earnings decline of 12.8% over the next few years. This pessimistic expectation contrasts with the company's recent 100% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BSX is in a strong downtrend. The price is currently testing key support at $52.75. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BSX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $85.19 (+60.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $55.58 - $63.40

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding BSX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 60.5% below Wall St target ($85.19)
CAUTION: 5-day price weakness (-5.3%) - monitor closely

Trading Range Analysis

30-Day Trading Range $55.58 - $63.40

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $52.75

Resistance Level $58.18

Current Trend Strong Downtrend

Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 14.10

Wall Street Target $85.19 (+60.5%)

Revenue Growth (YoY) 11.6%

Earnings Growth (YoY) 100.0%

Profit Margin 17.3%

Valuation Discount vs History -12.8% cheaper

PE vs Historical 14.1 vs 21.2 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -12.8% (market-implied from PE analysis)

1-Year Target $47.75 (-10%)

2-Year Target $42.98 (-19%)

3-Year Target $38.68 (-27%)

3-Yr Target (if PE normalizes) (PE: 14→21) $58.17 (+10%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.0, Growth: 11.4%) $114.75 (+116%)

Base: (SPY PE: 14.1, Growth: 11.4%) $73.39 (+38%)

Bear: (PE: 12.0, Growth: 11.4%) $62.38 (+18%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (14x PE) as earnings recover.

Trailing PE: 22.33 | Current EPS (TTM): $2.39

Bull Case $92.46 (+74%)

Analyst growth 57.5%, PE expands to 24.6

Base Case $84.05 (+58%)

Market implied 57.5%, PE stable at 22.3

Bear Case $36.29 (-32%)

Severe decline -20.0%, PE contracts to 19.0

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 14.1 to 21.2

Stabilization Target: $79.80 (+50.4%)

PE Expansion Potential: +50.4%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 14, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BSX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Ro Khanna BUY 2026-03-30

Ro Khanna SELL 2026-03-23

Ro Khanna SELL 2026-02-24

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BSX.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
SYK Stryker Corporation	BUY 32 analysts	$392	62 BUY
DXCM DexCom Inc	STRONG BUY 26 analysts	$84	60 BUY
MDT Medtronic PLC	BUY 32 analysts	$108	62 BUY
ABT Abbott Laboratories	BUY 28 analysts	$119	53 HOLD
PODD Insulet Corporation	STRONG BUY 23 analysts	$250	58 HOLD

SYK Stryker Corporati…

ABT Abbott Laboratori…

53 HOLD

PODD Insulet Corporati…

58 HOLD

Advanced BSX Option Strategies

Professional options setups generated by AI based on today's BSX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BSX

BSX Technical Chart BSX Price Prediction BSX Earnings Date BSX Investment Advisor BSX Fair Price Analyzer BSX Options Advisor BSX Options Chain BSX Options Analysis BSX Competitors

Compare BSX with Peers

BSX vs MDT
Which one to buy?

BSX vs SYK
Which one to buy?

BSX vs EW
Which one to buy?

BSX vs BAX
Which one to buy?

BSX vs BDX
Which one to buy?

SIBN vs BSX
Winner: BSX

BSX vs CVRX

LUCD vs BSX

Create New Comparison View All Competitors

Tradestie